Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


First Rounders: Cigall Kadoch

Cigall Kadoch is a co-founder of Foghorn Therapeutics and an assistant professor at the Dana-Farber Cancer Institute, where she runs the Kadoch lab. In her talk with Nature Biotechnology, she discusses launching Foghorn, how geography affects biotech success, and the link between interior design and scientific rigor.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

First Rounders: Cigall Kadoch. Nat Biotechnol 37, 837 (2019).

Download citation


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing